The fast-growing cosmetic dermatology space is attracting big players such as Torrent Pharmaceuticals, which is racing to make a big acquisition in the segment.
TO READ THE FULL STORY, SUBSCRIBE NOW FOR JUST RS 249 PER MONTH.
Key stories on business-standard.com are only available to premium subscribers.
Already a premium subscriber? LOGIN NOW
SUBSCRIBE TO PERSPECTIVES
What do you get on Business Standard Premium?
Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.
As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.
First published: Fri 26 Aug 2022. 06:10 IST